Conglian Yang

2.0k total citations
51 papers, 1.7k citations indexed

About

Conglian Yang is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Conglian Yang has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biomedical Engineering, 23 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Conglian Yang's work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (14 papers) and Immunotherapy and Immune Responses (14 papers). Conglian Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (14 papers) and Immunotherapy and Immune Responses (14 papers). Conglian Yang collaborates with scholars based in China, Sweden and United Kingdom. Conglian Yang's co-authors include Zhiping Zhang, Tingting Wu, Li Kong, Zhiping Zhang, Yan Qi, Qi Qiao, Xianya Qin, Lihuan Shang, Dan Zhang and Qingle Song and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Conglian Yang

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conglian Yang China 22 789 575 475 397 253 51 1.7k
Wenquan Ou South Korea 22 793 1.0× 544 0.9× 523 1.1× 344 0.9× 243 1.0× 34 1.5k
Xiaoling Xu China 29 978 1.2× 783 1.4× 609 1.3× 287 0.7× 186 0.7× 77 2.4k
Chunrong Yang China 25 730 0.9× 945 1.6× 538 1.1× 190 0.5× 205 0.8× 81 1.9k
Satya Siva Kishan Yalamarty United States 16 538 0.7× 630 1.1× 556 1.2× 163 0.4× 144 0.6× 26 1.5k
Yanjuan Huang China 30 983 1.2× 476 0.8× 415 0.9× 180 0.5× 263 1.0× 67 1.8k
Zaigang Zhou China 25 985 1.2× 367 0.6× 361 0.8× 312 0.8× 273 1.1× 41 1.7k
Jianqin Lu United States 25 983 1.2× 881 1.5× 894 1.9× 492 1.2× 424 1.7× 61 2.3k
Jianqin Wan China 20 712 0.9× 550 1.0× 649 1.4× 164 0.4× 164 0.6× 32 1.4k
Aniruddha Roy India 22 823 1.0× 612 1.1× 921 1.9× 229 0.6× 190 0.8× 51 2.0k
Nina Filipczak United States 23 720 0.9× 1.0k 1.8× 864 1.8× 198 0.5× 188 0.7× 44 2.2k

Countries citing papers authored by Conglian Yang

Since Specialization
Citations

This map shows the geographic impact of Conglian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conglian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conglian Yang more than expected).

Fields of papers citing papers by Conglian Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conglian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conglian Yang. The network helps show where Conglian Yang may publish in the future.

Co-authorship network of co-authors of Conglian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Conglian Yang. A scholar is included among the top collaborators of Conglian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conglian Yang. Conglian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Yulin Yu, Bin Xia, et al.. (2025). Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation. Journal of Controlled Release. 382. 113658–113658.
2.
3.
Zhang, Fangming, Siyu Zhao, Yulin Yu, et al.. (2025). Pathogen‐Mimicking Cancer Vaccine with Self‐Generated dsRNA Potentiates Innate Immunity Against Colon Cancer. Advanced Functional Materials. 35(46).
4.
Chen, Wei, Zijian Huang, Yuan Gao, et al.. (2025). Polyphenol-based coacervate droplets as building blocks for protocells and prototissues. Chemical Engineering Journal. 520. 165905–165905.
5.
Zhang, Fangming, Kexin Cui, Boning Niu, et al.. (2025). An immunogenic cell death dual-nanoamplifier for the reverse of chemotherapy resistance and immune escape in metastatic colon cancer. Nano Today. 62. 102678–102678. 3 indexed citations
6.
Zhang, Jiao, et al.. (2024). A laponite-based immunologically active gel delivery system for long-acting tumor vaccine. Journal of Controlled Release. 373. 201–215. 2 indexed citations
7.
Qin, Xianya, Hongbo Xu, Siyu Zhao, et al.. (2024). A novel biosynthesized vaccine based on tumor cells for peritoneal metastasis treatment in colon cancer. Chemical Engineering Journal. 484. 149224–149224. 5 indexed citations
8.
Wang, Shilong, Wei Chen, Li Kong, et al.. (2024). ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis. Nano Today. 59. 102530–102530. 8 indexed citations
9.
Qiao, Qi, Xiaonan Li, Yi Wang, et al.. (2024). Hybrid biomineralized nanovesicles to enhance inflamed lung biodistribution and reduce side effect of glucocorticoid for ARDS therapy. Journal of Controlled Release. 369. 746–764. 10 indexed citations
10.
Wang, Yi, Boning Niu, Yang Li, et al.. (2024). Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. Advanced Healthcare Materials. 13(28). e2401723–e2401723. 9 indexed citations
11.
Hu, Qian, Qi Xie, Xiao‐Nan Li, et al.. (2024). Apoptotic body based biomimetic hybrid nanovesicles to attenuate cytokine storms for sepsis treatment. Journal of Nanobiotechnology. 22(1). 775–775.
12.
Zhang, Tiantian, Xiaonan Li, Qi Qiao, et al.. (2024). In situ neutrophil apoptosis and macrophage efferocytosis mediated by Glycyrrhiza protein nanoparticles for acute inflammation therapy. Journal of Controlled Release. 369. 215–230. 31 indexed citations
13.
Qiao, Qi, Xiaonan Li, Kexin Cui, et al.. (2023). Apoptotic neutrophil-mediated inflammatory microenvironment regulation for the treatment of ARDS. Nano Today. 52. 101946–101946. 9 indexed citations
14.
Qin, Xianya, Ting Yang, Hongbo Xu, et al.. (2023). Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer. Journal of Controlled Release. 359. 359–372. 18 indexed citations
15.
Qiao, Qi, Ting Yang, Kexin Cui, et al.. (2021). Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharmaceutica Sinica B. 11(10). 3060–3091. 135 indexed citations
16.
Shang, Lihuan, Xue Jiang, Ting Yang, et al.. (2021). Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment. Acta Pharmaceutica Sinica B. 12(5). 2550–2567. 42 indexed citations
17.
Li, Jiali, Shichao Li, Yaqi Shen, et al.. (2021). A magnetic resonance nanoprobe with STING activation character collaborates with platinum-based drug for enhanced tumor immunochemotherapy. Journal of Nanobiotechnology. 19(1). 415–415. 8 indexed citations
18.
Yang, Conglian, et al.. (2018). Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition. Colloids and Surfaces B Biointerfaces. 169. 10–19. 23 indexed citations
19.
Yang, Conglian, Tingting Wu, Yan Qi, & Zhiping Zhang. (2017). Recent Advances in the Application of Vitamin E TPGS for Drug Delivery. Theranostics. 8(2). 464–485. 325 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenquan Ou Breakdown of academic impact, for papers by Xiaoling Xu Breakdown of academic impact, for papers by Chunrong Yang Breakdown of academic impact, for papers by Satya Siva Kishan Yalamarty Breakdown of academic impact, for papers by Yanjuan Huang Breakdown of academic impact, for papers by Zaigang Zhou Breakdown of academic impact, for papers by Jianqin Lu Breakdown of academic impact, for papers by Jianqin Wan Breakdown of academic impact, for papers by Aniruddha Roy Breakdown of academic impact, for papers by Nina Filipczak
Rankless by CCL
2026